The controversy of surgical seeding or metastasis of a recurrent ameloblastoma is discussed in this paper, where we present a case with a history of 28 years since primary diagnosis including several tumor removals and reconstructive events. 23 years after primary diagnosis, we removed a metastasis from the neck with similar histological features as the primary tumor and the following recurrences of the mandible. We argue that the removed tumor in the neck most possibly has its origin in surgical seeding of cells during earlier resection and reconstruction and not by common ways of metastasis. The seeding of tumor cells during tumor surgery and metastasis rate of malignant ameloblastoma is discussed and the literature in this area is reviewed in the paper.
INTRODUCTION
Ameloblastoma is an uncommon disease that represents 1% of all cysts and tumors diagnosed in the jaws [1, 2] . These benign slow-growing aggressive neoplasms show a distressing tendency to exhibit locally aggressive behavior and local recurrence in 50% to 72% of cases [3, 4] . Their potential for rare metastasis seems to be poorly understood [5] . Furthermore, tumor seeding during surgery leading to recurrence of the tumor appears to be rarely considered [6] . Hence, in this study we report a case of a 67-year-old female with a recurrent ameloblastoma, which presented in the submandibular region. Histology revealed an ameloblastoma with the same obviously benign growth pattern as in the primary lesion that before had presented in all the preceding surgeries of the jaw.
Although ameloblastoma of the jaws is most often considered by clinicians to be a benign tumor, some of these can be reclassified as malignant when metastases occur [7] . The 2005 World Health Organization (WHO) Classification of Odontogenic Tumors places metastasizing ameloblastoma under the general grouping of odontogenic carcinomas, along with ameloblastic carcinoma [8] . The typical WHO description of a metastasizing (malignant) ameloblastoma is an ameloblastoma that metastasizes in spite of a benign histological appearance [9] . This must be clearly distinguished from the ameloblastic carcinoma (primary type) which is characterized by histological malignant features in both the primary and metastatic sites [7, 10] .
A review of the literature regarding ameloblastoma indicates that there has been confusion about the terminology which has led to falsification of the frequency of metastasizing (malignant) ameloblastoma compared to ameloblastic carcinoma. Recent literature portends that the incidence of metastasizing (malignant) ameloblastoma has been overestimated while the incidence of ameloblastic carcinoma has been undervalued [11] .
CASE REPORT
dical checkup revealed a distinctly enlarged goitre, which considerably displaced the trachea and thus had to be treated primarily. After the thyroidectomy had been performed and the patient had recovered from this intervention, the patient underwent the reconstruction of the mandible in January 2008. During this operation a tumorous nodule in the submandibular/neck area was recognized and excised (Figures 1-4) . The histological examination of the sections showed structures of a recurrent ameloblastoma with the typical architecture-islands of epithelium distributed in a fibrous connective tissue stroma.
Retrospectively the micromorphology of the tumor tissue in the biopsies and surgical specimen remained essentially identical over time (Figures 5-8) . The tumor presented a follicular pattern with islands and sheaths of findings and at present there is no sign of another tumor manifestation at the submandibular/neck site (Figures 3  and 4 ) of or the site of primary tumor and furthermore no evidence of any spread of the disease.
DISCUSSION
Metastasizing ameloblastoma is a rare tumor and it is renowned for appearing in approximately 2% to 5% of cases [12] . The most recent literature shows that metastasis of well-differentiated ameloblastoma occurs more infrequently than formerly described [11] .
This might be due to the fact that some authors do not distinguish between the two categories of malignancies: metastasizing (malignant) ameloblastoma and ameloblastic carcinoma despite their distinct patterns [13, 14] . Therefore, the correct number of cases up to now is questionable. According to Ciment and Ciment up to 2002, fewer than 45 cases of ameloblastoma presenting metastasis have been reported [12] . Pursuant to a review by Van Dam et al. including the world literature until 2010 only 27 patient cases could be acknowledged complying with the diagnostic criteria of metastasizing (malignant) ameloblastoma [11] . Many factors have been affiliated with the probability of evolving metastases, including the duration of tumor presence, extent of initial disease, multiple surgical procedures, or radiation therapy [12, 15, 16] . However, even in patients without the characteristic history of multiple recurrences and operations, ameloblastoma may appear as a metastatic lesion, usually in the lungs, many years after treatment of the primary tumor [4] .
In the majority of cases metastasizing (malignant) ameloblastomas prevail as lung metastases, the rates vary between 71% -80%, followed by cervical lymph node metastases with 15% -28%, vertebrae, and, less frequently, the skull, liver, parotid gland, diaphragm, and brain [7, 11, 12, [16] [17] [18] .
The mode of spread of malignant ameloblastoma has not been clearly defined. Three routes are commonly mentioned: hematogenous, lymphatic, and by aspiration [15] . Vorzimer and Perla observed tumor casts within the bronchi and bronchioli [19] , which led investigators to believe that the metastatic mechanism was by aspiration [4, 15, 20] . Some controversies are apparent when reviewing the literature, because pulmonary metastatic lesions are most commonly found bilaterally, presenting multiple nodules, which supports the theory of hematogenous spread [15, 20] . Since there have been several reports of extrapulmonary spread, clearly metastases also occur by the hematogenous or lymphatic route, possibly due to disruption of the tumor and vessels during surgical resection [7, 21] . In contrast, according to Kunze et al., the pulmonary capillaries evidently provide an effective barrier for ameloblastoma cells and prevent further dissemination into the systemic circulation, since only some patients develop additional extrapulmonary metastases [20] .
Although scarcely discussed in the current literature the possibility of tumor cell implantation during surgical procedure must be emphasized. We strongly suspect a intraoperative seeding of tumor cells in our patient which resulted in recurrence of ameloblastoma in the submandibular region.
The most important element in therapy and management of ameloblastoma is adequate treatment of the primary lesion. Multiple surgeries significantly increase the risk of metastases and curettage opens pathways for dissemination of the tumor to adjacent structures which may lead to surgical seeding during operation [15, 22] . Therefore, en-bloc resection is the method of choice, using a 10-to 15-mm safety margin of normal bone, wherever possible, in order to prevent violating the tumor boundaries [22] .
Isolated and discrete lung metastases, particularly in the lung periphery have been treated by open thoracotomy and wedge resection, or even by lobotomy, depending on the number of lesions and their location [3, 15, 21] . Significant resection, with preservation of as much viable lung tissue as possible, has been the treatment of choice, since this is the only way to offer a significant disease-free interval. Chemotherapy has occasionally been used, with variable results, in limited cases presenting only a reduction in the size of the tumor; however, in most cases, it produced no effective improvement [3, 15] . Radiotherapy is recommended for inoperable metastatic deposits, but the response is unpredictable and, consequently, radiotherapy should be used only for palliative care [12, 15, 17] .
According to a recently published review by Dam et al. the average time from diagnosis of primary to metastasis is 18 years [11] . Our patient showed a recurrent ameloblastoma about 23 years after the primary tumor diagnosis. The median disease-free interval of previously reported metastatic ameloblastoma cases was 9 years [17] . Our patient underwent numerous operations and the metastasis occurred 3 years after hemimandibulectomy and reconstruction plate plus radial forearm-flap. However, it is important to note that this metastatic lesion was found incidentally, since the patient presented no symptoms in reference to her tumor.
